Boston Gene Therapy Gives Deaf Children a Chance to Hear

Everett Tynes sat in his hospital bed at Boston Children's Hospital, flipping through a musical book he couldn't hear, just days before a treatment that could change his life forever.

The young boy was preparing to receive an experimental gene therapy designed to restore hearing in children born deaf. Boston Children's Hospital is one of the pioneering centers offering this revolutionary treatment that targets the genetic causes of deafness.

His parents, Leah Hamel and Andrew Tynes, traveled to Boston with Everett and his 9-week-old brother Jack Wilder, staying at an Airbnb in Brookline while preparing for the procedure. The family navigated the emotional journey of hoping for a medical breakthrough while caring for two young children far from home.

The gene therapy works by delivering functional genes to the inner ear, potentially allowing children to develop hearing they were born without. This represents a fundamental shift from traditional treatments like cochlear implants, which amplify sound rather than address the underlying genetic cause.

Regeneron, the maker of the gene therapy, is providing the treatment free of charge to participating families. However, families still face significant expenses for travel, accommodations, and hospital costs not covered by the experimental program.

The days leading up to the surgery were filled with ordinary moments made extraordinary by anticipation. Everett played with lights, took selfies on his mom's phone, and blew raspberries, unaware that his silent world might soon be filled with sound.

Why This Inspires

This treatment represents hope for thousands of families worldwide who have children born with genetic hearing loss. For generations, deafness caused by genetic mutations had no cure, only management through devices and sign language.

The fact that a major pharmaceutical company is offering this cutting-edge therapy at no cost to families shows how medical innovation can prioritize access over profit. While travel and hospital expenses remain challenging, removing the treatment cost barrier opens possibilities for families who might otherwise never afford such advanced care.

Every child who receives this therapy helps researchers understand how to refine and improve it for future patients. Everett and families like his are pioneers, turning scientific possibility into medical reality.

The images of Everett preparing for surgery capture the beautiful tension between childhood innocence and medical hope, reminding us that behind every breakthrough are real families taking courageous leaps of faith.